🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons

RecruitingNAAges 18 Years - anyAllUniversity of Regensburg
NCT07788729 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Optimal patient-centered care is often not being delivered to cancer patients, especially to vulnerable populations like those living in underserved rural areas. This body of work will develop and pilot test a multicomponent intervention approach designed to improve the care and outcomes of cancer patients and their support persons (SPs) during and following their therapeutic journey. The intervention will involve the provision of social prescriptions and web-based micro-learning modules, as well as stepwise care based on ongoing monitoring of symptom burden and health. This project uses the strengths of innovative, individually tailored communication strategies and a comprehensive low-cost approach that are likely to support fair and equal patient access to optimal care beyond the funding period. By using a patient-driven approach in an interdisciplinary setting, it is anticipated that

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria for patients: * aged at least 18 years * primary diagnosis of early-stage or advanced-stage lung cancer, colorectal cancer, hematological neoplasm or malignant melanoma within the past 12 months * expected survival of at least 18 months * sufficient German language proficiency to complete questionnaires and interviews * attendance at the medical oncology units of participating hospitals * provision of written informed consent * ECOG Performance Status 0-2 * ability to name an eligible SP. Inclusion criteria for Support Persons: * being nominated by the patient as someone who provides support, encouragement or assistance in coping with their cancer * aged at least 18 years * proficiency in German * provision of written informed consent. Exclusion Criteria: Inability to * provide informed consent * independently complete interviews and/or questionnaires due to impaired speech, vigilance, or comprehension.
💊

What it tests

  • PRISMA-interventions
📍

Where

8 sites
University Hospital Augsburg
Augsburg, Germany
University Hospital Erlangen
Erlangen, Germany
University Hospital Regensburg
Regensburg, Germany
University Regensburg
Regensburg, Germany
University Hospital Würzburg
Würzburg, Germany
Faculty of Law, Business & Economics, Inst. for Healthcare Management & Health Sciences
Bayreuth, Germany
Charité - University Medicine Berlin
Berlin, Germany
University Hospital Köln
Cologne, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy